Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.
about
Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cladribine, gemcitabine, busul ...... ymphomas: A preclinical study.
@en
type
label
Cladribine, gemcitabine, busul ...... ymphomas: A preclinical study.
@en
prefLabel
Cladribine, gemcitabine, busul ...... ymphomas: A preclinical study.
@en
P2093
P2860
P1476
Cladribine, gemcitabine, busul ...... ymphomas: A preclinical study.
@en
P2093
Benigno C Valdez
Borje S Andersson
Esmeralda C Teo
Richard E Champlin
Yago Nieto
P2860
P304
P356
10.1016/J.EXPHEM.2016.03.001
P577
2016-03-11T00:00:00Z